Ignite Creation Date:
2024-05-05 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 9:56 AM
Study NCT ID:
NCT00768339
Status:
TERMINATED
Last Update Posted:
2011-07-13
First Post:
2008-10-06
Brief Title:
A Phase 1-2 Multicenter Open-Label Study of AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas
Sponsor:
Aegera Therapeutics
Organization:
Aegera Therapeutics
Organization Data
Organization:
Aegera Therapeutics
Class:
INDUSTRY
Study ID:
AEG35156-204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Aegera Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Jacques Jolivet MD Senior VP Clinical
Old Organization:
Aegera Therapeutics Inc
Collaborators
| Name | Class |
|---|---|
| The Leukemia and Lymphoma Society | OTHER |